Structural basis for CBP/p300 transcriptional regulation

CBP/p300 转录调控的结构基础

基本信息

  • 批准号:
    8825432
  • 负责人:
  • 金额:
    $ 40.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-06-10 至 2016-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): CREB binding protein (CBP) and p300 are general transcriptional regulators that integrate numerous signal transduction pathways in eukaryotic cells, functioning both as coactivators and repressors of gene expression. They are essential for such basic cellular functions as growth, differentiation, apoptosis, and embryonic development. They also function as tumor suppressors and regulate key genes that control cellular proliferation, tumorigenesis, and cancer progression. Because of their function at the nexus of critical cell signaling networks, CBP and p300 are targeted by many cellular and viral oncoproteins. The goals of the present proposal are to elucidate the structural and molecular basis by which CBP and p300 perform their central regulatory roles to protect against or promote oncogenic transformation. The research will focus on elucidation of the molecular determinants by which CBP and p300 interact with the tumor suppressor p53 and with transforming oncoproteins from human papillomavirus. p53 is activated by a complex phosphorylation cascade that results in enhanced interactions between the p53 transcriptional activation domain and CBP/p300. The E6 and E7 oncoproteins from high risk human papillomavirus recognize and bind CBP/p300 to repress p53-mediated transcriptional pathways, prevent apoptosis, and transform the host cell. State-of-the-art structural, biophysical, and proteomics tools will be utilized to elucidate the molecular basis for key CBP/p300 interactions responsible for activation of the p53 response to DNA damage, immortalization and transformation of the host cell by high risk human papillomavirus strains, and regulation and repression of damage response genes. This research will provide novel insights into the mechanism of activation of p53-regulated genes in response to genotoxic stress, into the molecular interactions through which high risk human papillomavirus oncoproteins subvert the cellular regulatory machinery to immortalize and transform the cell, and into the function of CBP as a transcriptional repressor.
描述(申请人提供):CREB结合蛋白(CBP)和p300是真核细胞中整合多种信号转导途径的通用转录调节因子,既是基因表达的辅助激活因子,也是基因表达的抑制因子。它们对细胞的生长、分化、凋亡和胚胎发育等基本功能是必不可少的。它们还发挥肿瘤抑制因子的作用,并调节控制细胞增殖、肿瘤发生和癌症进展的关键基因。由于其在关键细胞信号网络中的作用,CBP和p300是许多细胞和病毒癌蛋白的靶标。本提案的目的是阐明CBP和p300发挥其核心调控作用以防止或促进致癌转化的结构和分子基础。这项研究将集中在阐明CBP和p300与肿瘤抑制基因P53以及人乳头瘤病毒转化癌蛋白相互作用的分子决定因素。P53被复杂的磷酸化级联反应激活,导致P53转录激活结构域和CBP/p300之间的相互作用增强。高危型人乳头瘤病毒的E6和E7癌蛋白识别和结合CBP/p300,以抑制P53介导的转录途径,防止细胞凋亡,并转化宿主细胞。将利用最先进的结构、生物物理和蛋白质组学工具来阐明关键的CBP/p300相互作用的分子基础,这些相互作用负责激活P53对DNA损伤的反应,使宿主细胞永生化和被高风险的人乳头瘤病毒株转化,以及对损伤反应基因的调节和抑制。这项研究将为以下方面提供新的见解:响应遗传毒性应激激活P53调节基因的机制;高危人乳头瘤病毒癌蛋白通过分子相互作用颠覆细胞调节机制使细胞永生和转化;以及CBP作为转录抑制因子的功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER Edwin WRIGHT其他文献

PETER Edwin WRIGHT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER Edwin WRIGHT', 18)}}的其他基金

Structural characterization of large eukaryotic proteins containing both folded and disordered domains
含有折叠和无序结构域的大型真核蛋白质的结构表征
  • 批准号:
    10552345
  • 财政年份:
    2023
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular mechanisms of transthyretin amyloidosis
运甲状腺素蛋白淀粉样变性的分子机制
  • 批准号:
    10115719
  • 财政年份:
    2020
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular mechanisms of transthyretin amyloidosis
运甲状腺素蛋白淀粉样变性的分子机制
  • 批准号:
    10599188
  • 财政年份:
    2020
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular mechanisms of transthyretin amyloidosis
运甲状腺素蛋白淀粉样变性的分子机制
  • 批准号:
    10372930
  • 财政年份:
    2020
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300
CBP/p300 调节细胞应激反应途径的分子基础
  • 批准号:
    10436187
  • 财政年份:
    2018
  • 资助金额:
    $ 40.74万
  • 项目类别:
Molecular Basis for Regulation of Cellular Stress Response Pathways by CBP/p300
CBP/p300 调节细胞应激反应途径的分子基础
  • 批准号:
    10172869
  • 财政年份:
    2018
  • 资助金额:
    $ 40.74万
  • 项目类别:
High Performance Digital NMR Spectrometer Console
高性能数字核磁共振波谱仪控制台
  • 批准号:
    7793710
  • 财政年份:
    2010
  • 资助金额:
    $ 40.74万
  • 项目类别:
Structural basis for CBP/p300 transcriptional regulation
CBP/p300 转录调控的结构基础
  • 批准号:
    7909484
  • 财政年份:
    2009
  • 资助金额:
    $ 40.74万
  • 项目类别:
Recognition of Regulatory and Pathogenic RNA by Muscleblind Zinc Fingers
肌盲锌指识别调节性和致病性 RNA
  • 批准号:
    7924930
  • 财政年份:
    2009
  • 资助金额:
    $ 40.74万
  • 项目类别:
International Conference on Magnetic Resonance in Biological Systems 2008
2008 年生物系统磁共振国际会议
  • 批准号:
    7483664
  • 财政年份:
    2008
  • 资助金额:
    $ 40.74万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.74万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了